Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-22

Clinical Trial Update: Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial comparing mycophenolate mofetil to cyclosporin A for treatment of autoimmune hepatitis-primary biliary cholangitis overlap syndrome in patients no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cyclosporin A (cyclosporine)
  • MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: West China Hospital | Conditions: Hepatitis, Autoimmune, Primary Biliary Cholangitis | Phase 4 | Status: UNKNOWN